Barings’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-392
| Closed | -$227K | – | 196 |
|
|
2025
Q4 | $227K | Sell |
392
-24
| -6% | -$13.6K | ﹤0.01% | 156 |
|
|
2025
Q3 | $202K | Buy |
+416
| New | +$194K | ﹤0.01% | 165 |
|
|
2023
Q3 | – | Sell |
-2,204
| Closed | -$1.15M | – | 171 |
|
|
2023
Q2 | $1.15M | Hold |
2,204
| – | – | 0.04% | 112 |
|
|
2023
Q1 | $1.27M | Buy |
2,204
+394
| +22% | +$222K | 0.04% | 100 |
|
|
2022
Q4 | $997K | Sell |
1,810
-78
| -4% | -$41.3K | 0.04% | 120 |
|
|
2022
Q3 | $958K | Sell |
1,888
-547
| -22% | -$306K | 0.04% | 120 |
|
|
2022
Q2 | $1.32M | Buy |
2,435
+1,184
| +95% | +$652K | 0.05% | 147 |
|
|
2022
Q1 | $739K | Sell |
1,251
-74
| -6% | -$42.5K | 0.02% | 187 |
|
|
2021
Q4 | $884K | Sell |
1,325
-204
| -13% | -$127K | 0.02% | 196 |
|
|
2021
Q3 | $873K | Sell |
1,529
-1,105
| -42% | -$606K | 0.02% | 201 |
|
|
2021
Q2 | $1.33M | Sell |
2,634
-1,599
| -38% | -$754K | 0.03% | 191 |
|
|
2021
Q1 | $1.93M | Sell |
4,233
-641
| -13% | -$306K | 0.05% | 172 |
|
|
2020
Q4 | $2.27M | Sell |
4,874
-8,136
| -63% | -$3.81M | 0.06% | 160 |
|
|
2020
Q3 | $5.74M | Sell |
13,010
-456
| -3% | -$188K | 0.13% | 130 |
|
|
2020
Q2 | $3.82M | Hold |
13,466
| – | – | 0.13% | 136 |
|
|
2020
Q1 | $3.82M | Sell |
13,466
-5,723
| -30% | -$1.8M | 0.13% | 136 |
|
|
2019
Q4 | $6.23M | Sell |
19,189
-9,156
| -32% | -$2.78M | 0.17% | 121 |
|
|
2019
Q3 | $8.26M | Sell |
28,345
-836
| -3% | -$239K | 0.18% | 112 |
|
|
2019
Q2 | $8.57M | Buy |
29,181
+10,932
| +60% | +$3.01M | 0.19% | 109 |
|
|
2019
Q1 | $5M | Sell |
18,249
-2,268
| -11% | -$564K | 0.11% | 152 |
|
|
2018
Q4 | $4.59M | Buy |
20,517
+15,212
| +287% | +$3.57M | 0.08% | 149 |
|
|
2018
Q3 | $1.29M | Sell |
5,305
-570
| -10% | -$131K | 0.02% | 437 |
|
|
2018
Q2 | $1.22M | Sell |
5,875
-3,934
| -40% | -$835K | 0.02% | 472 |
|
|
2018
Q1 | $2.02M | Hold |
9,809
| – | – | 0.03% | 369 |
|
|
2017
Q4 | $1.86M | Hold |
9,809
| – | – | 0.02% | 400 |
|
|
2017
Q3 | $1.86M | Hold |
9,809
| – | – | 0.03% | 328 |
|
|
2017
Q2 | $1.71M | Sell |
9,809
-18,929
| -66% | -$3.18M | 0.05% | 350 |
|
|
2017
Q1 | $4.41M | Buy |
28,738
+14,369
| +100% | +$2.2M | 0.05% | 354 |
|
|
2016
Q4 | $2.03M | Buy |
14,369
+5,310
| +59% | +$783K | 0.05% | 269 |
|
|
2016
Q3 | $1.44M | Sell |
9,059
-22,630
| -71% | -$3.49M | 0.04% | 358 |
|
|
2016
Q2 | $4.68M | Buy |
+31,689
| New | +$4.68M | 0.12% | 109 |
|
|
2016
Q1 | – | Sell |
-12,779
| Closed | -$1.81M | – | 977 |
|
|
2015
Q4 | $1.81M | Hold |
12,779
| – | – | 0.05% | 323 |
|
|
2015
Q3 | $1.56M | Sell |
12,779
-14,025
| -52% | -$1.83M | 0.04% | 345 |
|
|
2015
Q2 | $3.48M | Buy |
26,804
+19,480
| +266% | +$2.54M | 0.11% | 195 |
|
|
2015
Q1 | $984K | Sell |
7,324
-12,650
| -63% | -$1.63M | 0.02% | 512 |
|
|
2014
Q4 | $2.5M | Buy |
19,974
+1,640
| +9% | +$199K | 0.06% | 256 |
|
|
2014
Q3 | $2.23M | Buy |
18,334
+20
| +0.1% | +$2.43K | 0.05% | 282 |
|
|
2014
Q2 | $2.16M | Sell |
18,314
-15,720
| -46% | -$1.85M | 0.06% | 304 |
|
|
2014
Q1 | $4.09M | Buy |
34,034
+3,130
| +10% | +$372K | 0.13% | 152 |
|
|
2013
Q4 | $3.44M | Sell |
30,904
-2,850
| -8% | -$283K | 0.14% | 156 |
|
|
2013
Q3 | $3.11M | Buy |
33,754
+9,900
| +42% | +$895K | 0.13% | 165 |
|
|
2013
Q2 | $2.02M | Buy |
+23,854
| New | +$1.99M | 0.09% | 239 |
|
Other funds holding TMO
Barings's TMO Position: Q1 2026 in Review
Barings sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 392 shares — an estimated $227K sold.
Barings first reported a position in TMO in Q2 2013 and held it in 42 quarters. The position peaked at $8.57M in Q2 2019. 2,600 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Barings reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
- Barings sold 392 Thermo Fisher Scientific shares in Q1 2026, an estimated $227K.
- Barings first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 42 quarters.
- Barings's Thermo Fisher Scientific position peaked at $8.57M in Q2 2019.
- 2,600 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Barings's 13F filing for Q1 2026, filed 6 May 2026.